UPDATED Dec 05, 2023
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| HYLHyloris Pharmaceuticals | €12.50 | 0.4% | -6.7% | €350.0m | €19.90 | PS113.7x | E116.2% | n/a | ||
| ARGXargenx | €428.90 | 5.0% | 15.1% | €25.3b | €512.28 | PS26.6x | E71.5% | n/a | ||
| MITRAMithra Pharmaceuticals | €1.21 | 2.0% | -70.8% | €83.8m | €1.90 | PS1.3x | E71.3% | 0% | ||
| MDXHMDxHealth | €2.99 | 1.7% | -53.0% | €81.6m | €7.00 | PS1.4x | E59.7% | n/a | ||
| UCBUCB | €73.08 | 7.9% | 2.7% | €13.9b | €101.16 | PE41.8x | E29.9% | 1.8% |